HCMT
AERI

Highland Capital Management (Texas)’s Aerie Pharmaceuticals AERI Stock Holding History

Highland Capital Management (Texas)’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.33M Buy
+45,000
New +$1.73M 0.08% 183

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Highland Capital Management (Texas)'s AERI Position: Q2 2019 in Review

Highland Capital Management (Texas) increased its Aerie Pharmaceuticals (AERI) stake by 49% in Q2 2019, buying an estimated $9.81M and bringing the position to 778,791 shares worth $23M. The position accounts for 1.35% of the portfolio, ranked #14.

Highland Capital Management (Texas) first reported a position in AERI in Q1 2017 and has held it in 8 quarters since. The position peaked at $24.9M in Q1 2019. 167 funds tracked by Wall St. Rank hold AERI as of Q2 2019.

  • Highland Capital Management (Texas) held 778,791 shares of Aerie Pharmaceuticals worth $23M as of Q2 2019.
  • Highland Capital Management (Texas) bought 254,700 Aerie Pharmaceuticals shares in Q2 2019, an estimated $9.81M.
  • Aerie Pharmaceuticals made up 1.35% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #14 holding.
  • Highland Capital Management (Texas) first reported a position in Aerie Pharmaceuticals in Q1 2017 and has held it in 8 quarters since.
  • Highland Capital Management (Texas)'s Aerie Pharmaceuticals position peaked at $24.9M in Q1 2019.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.